A quantitative approach to screen for nephrotoxic compounds in vitro

Journal of the American Society of Nephrology

Volumn 27, Issue 4, 2016, Pages 1015-1028

  Adler, Melanie ^a,b,g   Ramm, Susanne ^a,g   Hafner, Marc ^a,g   Muhlich, Jeremy L ^a,g   Gottwald, Esther Maria ^b   Weber, Elijah ^c   Jaklic, Alenka ^c   Ajay, Amrendra Kumar ^b   Svoboda, Daniel ^d   Auerbach, Scott ^e   Kelly, Edward J ^c   Himmelfarb, Jonathan ^f   Vaidya, Vishal S ^a,b,g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 1; ARISTOLOCHIC ACID; BIOLOGICAL MARKER; CADHERIN; CADMIUM CHLORIDE; CARBOPLATIN; CISPLATIN; COLLAGEN TYPE 4; CYCLOSPORIN A; CYTOKERATIN 18; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEME OXYGENASE 1; MEGALIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 1; NERVE CELL ADHESION MOLECULE; OCHRATOXIN; ORGANIC CATION TRANSPORTER 2; PROTEIN ZO1; REACTIVE OXYGEN METABOLITE; TOBRAMYCIN; TOXIC SUBSTANCE; UVOMORULIN;

ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC CORRELATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NEPHROTOXICITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE STUDY; SCREENING; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; ENZYMOLOGY; GENETICS; KIDNEY DISEASE; PROCEDURES; TOXICITY TESTING;

BIOMARKERS; CELLS, CULTURED; HEME OXYGENASE-1; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; TOXICITY TESTS;

EID: 85017054630     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010060     Document Type: Article

References (43)

1. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F: Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 28: 436–440, 2010
2. Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS: Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis 17: 254–264, 2010
3. Hartung T: Toxicology for the twenty-first century. Nature 460: 208–212, 2009
4. Fuchs TC, Hewitt P: Biomarkers for drug-induced renal damage and nephrotoxicity – an overview for applied toxicology. AAPS J 13: 615–631, 2011
5. Sun H, Xia M, Austin CP, Huang R: Paradigm shift in toxicity testing and modeling. AAPS J 14: 473–480, 2012
6. Shukla SJ, Huang R, Austin CP, Xia M: The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. Drug Discov Today 15: 997–1007, 2010
7. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B: HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48–57, 1994
8. Gstraunthaler G, Pfaller W, Kotanko P: Biochemical characterization of renal epithelial cell cultures (LLC-PK1 and MDCK). Am J Physiol 248: F536–F544, 1985
9. Jenkinson SE, Chung GW, van Loon E, Bakar NS, Dalzell AM, Brown CD: The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflugers Arch 464: 601–611, 2012
10. Li Y, Oo ZY, Chang SY, Huang P, Eng KG, Zeng JL, Kaestli AJ, Gopalan B, Kandasamy K, Tasnim F, Zink D: An in vitro method for the prediction of renal proximal tubular toxicity in humans. Toxicol Res (Camb) 2: 352–365, 2013
11. Perazella MA: Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 4: 1275–1283, 2009
12. Li Y, Kandasamy K, Chuah JK, Lam YN, Toh WS, Oo ZY, Zink D: Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells. Mol Pharm 11: 1982–1990, 2014
13. Lash LH, Putt DA, Cai H: Membrane transport function in primary cultures of human proximal tubular cells. Toxicology 228: 200–218, 2006
14. Lash LH, Putt DA, Cai H: Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells. Toxicology 244: 56–65, 2008
15. Lamb J: The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7: 54–60, 2007
16. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV: Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28: 478–485, 2010
17. Kelly EJ, Wang Z, Voellinger JL, Yeung CK, Shen DD, Thummel KE, Zheng Y, Ligresti G, Eaton DL, Muczynski KA, Duffield JS, Neumann T, Tourovskaia A, Fauver M, Kramer G, Asp E, Himmelfarb J: Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system. Stem Cell Res Ther 4[Suppl 1]: S17, 2013
18. Zager RA, Johnson AC, Becker K: Plasma and urinary heme oxygenase-1 in AKI. J Am Soc Nephrol 23: 1048–1057, 2012
19. Astashkina AI, Mann BK, Prestwich GD, Grainger DW: A 3D organoid kidney culture model engineered for high-throughput nephrotoxicity assays. Biomaterials 33: 4700–4711, 2012
20. Huang JX, Blaskovich MA, Cooper MA: Cell- and biomarker-based assays for predicting nephrotoxicity. Expert Opin Drug Metab Toxicol 10: 1621–1635, 2014
21. Attene-Ramos MS, Miller N, Huang R, Michael S, Itkin M, Kavlock RJ, Austin CP, Shinn P, Simeonov A, Tice RR, Xia M: The Tox21 robotic platform for the assessment of environmental chemicals – from vision to reality. Drug Discov Today 18: 716–723, 2013
22. Tice RR, Austin CP, Kavlock RJ, Bucher JR: Improving the human hazard characterization of chemicals: a Tox21 update. Environ Health Perspect 121: 756–765, 2013
23. Agarwal A, Bolisetty S: Adaptive responses to tissue injury: role of heme oxygenase-1. Trans Am Clin Climatol Assoc 124: 111–122, 2013
24. Nath KA: Heme oxygenase-1 and acute kidney injury. Curr Opin Nephrol Hypertens 23: 17–24, 2014
25. Gozzelino R, Jeney V, Soares MP: Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323–354, 2010
26. Takahashi M, Doré S, Ferris CD, Tomita T, Sawa A, Wolosker H, Borchelt DR, Iwatsubo T, Kim SH, Thinakaran G, Sisodia SS, Snyder SH: Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer’s disease. Neuron 28: 461–473, 2000
27. Harder Y, Amon M, Georgi M, Scheuer C, Schramm R, Rücker M, Pittet B, Erni D, Menger MD: Aging is associated with an increased susceptibility to ischaemic necrosis due to microvascular perfusion failure but not a reduction in ischaemic tolerance. Clin Sci (Lond) 112: 429–440, 2007
28. Regehly M, Greish K, Rancan F, Maeda H, Böhm F, Röder B: Water-soluble polymer conjugates of ZnPP for photodynamic tumor therapy. Bioconjug Chem 18: 494–499, 2007
29. Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Kunzli B, Autschbach F, Meuer S, Buchler MW, Friess H: Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clinical cancer research: an official journal of the American Association for Cancer Research, 11: 3790–3798, 2005.
30. Abraham NG, Kappas A: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79–127, 2008
31. Yokoyama T, Shimizu M, Ohta K, Yuno T, Okajima M, Wada T, Toma T, Koizumi S, Yachie A: Urinary heme oxygenase-1 as a sensitive indicator of tubulointerstitial inflammatory damage in various renal diseases. Am J Nephrol 33: 414–420, 2011
32. Shan J, Schwartz RE, Ross NT, Logan DJ, Thomas D, Duncan SA, North TE, Goessling W, Carpenter AE, Bhatia SN: Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol 9: 514–520, 2013
33. Huang R, Xia M, Cho MH, Sakamuru S, Shinn P, Houck KA, Dix DJ, Judson RS, Witt KL, Kavlock RJ, Tice RR, Austin CP: Chemical genomics profiling of environmental chemical modulation of human nuclear receptors. Environ Health Perspect 119: 1142–1148, 2011
34. Cihlar T, Ho ES, Lin DC, Mulato AS: Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 20: 641–648, 2001
35. Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Endou H: Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300: 918–924, 2002
36. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM: The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 278: 37561–37568, 2003
37. Chai LY, Netea MG, Tai BC, Khin LW, Vonk AG, Teo BW, Schlamm HT, Herbrecht R, Donnelly JP, Troke PF, Kullberg BJ: An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity. J Antimicrob Chemother 68: 1655–1659, 2013
38. Bhatia SN, Ingber DE: Microfluidic organs-on-chips. Nat Biotechnol 32: 760–772, 2014
39. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV: Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 1: 200–208, 2008
40. Peck D, Crawford ED, Ross KN, Stegmaier K, Golub TR, Lamb J: A method for high-throughput gene expression signature analysis. Genome Biol 7: R61, 2006
41. Blodgett AB, Kothinti RK, Kamyshko I, Petering DH, Kumar S, Tabatabai NM: A fluorescence method for measurement of glucose transport in kidney cells. Diabetes Technol Ther 13: 743–751, 2011
42. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15, 2003
43. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264, 2003